FINLEY JOHN DAVID (Chief Financial Officer) purchased 13.4% of their position (1K shares) of PALISADE BIO, INC. on the open market
Open‑market purchase worth $4.8K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/28/2024ACC: 0001493152-24-021431
Officer· Chief Financial Officer
Since Apr 2021
+1K
Net shares
Net buyer
$4.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1K acquired
Non-Derivative Transactions1
Common Stock, par value $0.01
Direct
Shares
+1K
Price / share
$4.81
Trade value
$4.81K
% of position
13.4%
5/24/2024
7.44K→8.44K
Total
Net shares
+1K
Net value
$4.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01 Direct | 5/24/2024 | P · Purchase | +1K | $4.81 | $4.81K | 13.4% | 7.44K | 8.44K |
| Total | +1K | $4.81K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock, par value $0.01
IndirectShares owned51.00
Total
51.00 indirect51.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.01 | 51.00 | Indirect |
| Total | 51.00 | 51.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported